Cargando…

Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction

Huang-Lian-Jie-Du Decoction (HLJDD) is a classical Traditional Chinese Medicine (TCM) formula with heat-dissipating and detoxifying effects. It is used to treat inflammation-associated diseases. However, no systematic pharmacokinetic (PK) and pharmacodynamic (PD) data concerning the activity of HLJD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Wei, Zuo, Ran, Wang, Yao-Nan, Wang, Hong-Jie, Yang, Jian, Xin, Shao-Kun, Han, Ling-Yu, Zhao, Hai-Yu, Han, Shu-Yan, Gao, Bo, Hu, Hao, Hu, Yuan-Jia, Bian, Bao-Lin, Si, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900566/
https://www.ncbi.nlm.nih.gov/pubmed/27280291
http://dx.doi.org/10.1371/journal.pone.0156256
_version_ 1782436659426492416
author Ren, Wei
Zuo, Ran
Wang, Yao-Nan
Wang, Hong-Jie
Yang, Jian
Xin, Shao-Kun
Han, Ling-Yu
Zhao, Hai-Yu
Han, Shu-Yan
Gao, Bo
Hu, Hao
Hu, Yuan-Jia
Bian, Bao-Lin
Si, Nan
author_facet Ren, Wei
Zuo, Ran
Wang, Yao-Nan
Wang, Hong-Jie
Yang, Jian
Xin, Shao-Kun
Han, Ling-Yu
Zhao, Hai-Yu
Han, Shu-Yan
Gao, Bo
Hu, Hao
Hu, Yuan-Jia
Bian, Bao-Lin
Si, Nan
author_sort Ren, Wei
collection PubMed
description Huang-Lian-Jie-Du Decoction (HLJDD) is a classical Traditional Chinese Medicine (TCM) formula with heat-dissipating and detoxifying effects. It is used to treat inflammation-associated diseases. However, no systematic pharmacokinetic (PK) and pharmacodynamic (PD) data concerning the activity of HLJDD under inflammatory conditions is available to date. In the present study, the concentration-time profiles and the hepatic clearance rates (HCR) of 41 major components in rat plasma in response to the oral administration of a clinical dose of HLJDD were investigated by LC-QqQ-MS using a dynamic multiple reaction monitoring (DMRM) method. Additionally, the levels of 7 cytokines (CKs) in the plasma and the body temperature of rats were analyzed. Furthermore, a PK-PD model was established to describe the time course of the hemodynamic and anti-inflammatory effects of HLJDD. As one of the three major active constituents in HLJDD, iridoids were absorbed and eliminated more easily and quickly than alkaloids and flavonoids. Compared with the normal controls, the flavonoids, alkaloids and iridoids in inflamed rats exhibited consistently changing trends of PK behaviors, such as higher bioavailability, slower elimination, delays in reaching the maximum concentration (T(max)) and longer substantivity. The HCR of iridoids was different from that of alkaloids and flavonoids in inflamed rats. Furthermore, excellent pharmacodynamic effects of HLJDD were observed in inflamed rats. The levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, IL-10, and macrophage inflammatory protein-2 (MIP-2) and body temperature significantly decreased after the administration of HLJDD. Based on PK-PD modeling with the three-phase synchronous characterization of time-concentration-effect, flavonoids exhibited one mechanism of action in the anti-inflammatory process, while iridoids and alkaloids showed another mechanism of action. Taken together, the results demonstrated that HLJDD may restrain inflammation synergistically via its major constituents (alkaloids, flavonoids and iridoids). A correlation between the exposure concentration of different types of compounds and their anti-inflammatory effects in the body was shown. This study provides a comprehensive understanding of the anti-inflammatory activity of HLJDD.
format Online
Article
Text
id pubmed-4900566
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49005662016-06-24 Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction Ren, Wei Zuo, Ran Wang, Yao-Nan Wang, Hong-Jie Yang, Jian Xin, Shao-Kun Han, Ling-Yu Zhao, Hai-Yu Han, Shu-Yan Gao, Bo Hu, Hao Hu, Yuan-Jia Bian, Bao-Lin Si, Nan PLoS One Research Article Huang-Lian-Jie-Du Decoction (HLJDD) is a classical Traditional Chinese Medicine (TCM) formula with heat-dissipating and detoxifying effects. It is used to treat inflammation-associated diseases. However, no systematic pharmacokinetic (PK) and pharmacodynamic (PD) data concerning the activity of HLJDD under inflammatory conditions is available to date. In the present study, the concentration-time profiles and the hepatic clearance rates (HCR) of 41 major components in rat plasma in response to the oral administration of a clinical dose of HLJDD were investigated by LC-QqQ-MS using a dynamic multiple reaction monitoring (DMRM) method. Additionally, the levels of 7 cytokines (CKs) in the plasma and the body temperature of rats were analyzed. Furthermore, a PK-PD model was established to describe the time course of the hemodynamic and anti-inflammatory effects of HLJDD. As one of the three major active constituents in HLJDD, iridoids were absorbed and eliminated more easily and quickly than alkaloids and flavonoids. Compared with the normal controls, the flavonoids, alkaloids and iridoids in inflamed rats exhibited consistently changing trends of PK behaviors, such as higher bioavailability, slower elimination, delays in reaching the maximum concentration (T(max)) and longer substantivity. The HCR of iridoids was different from that of alkaloids and flavonoids in inflamed rats. Furthermore, excellent pharmacodynamic effects of HLJDD were observed in inflamed rats. The levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), IL-1β, IL-10, and macrophage inflammatory protein-2 (MIP-2) and body temperature significantly decreased after the administration of HLJDD. Based on PK-PD modeling with the three-phase synchronous characterization of time-concentration-effect, flavonoids exhibited one mechanism of action in the anti-inflammatory process, while iridoids and alkaloids showed another mechanism of action. Taken together, the results demonstrated that HLJDD may restrain inflammation synergistically via its major constituents (alkaloids, flavonoids and iridoids). A correlation between the exposure concentration of different types of compounds and their anti-inflammatory effects in the body was shown. This study provides a comprehensive understanding of the anti-inflammatory activity of HLJDD. Public Library of Science 2016-06-09 /pmc/articles/PMC4900566/ /pubmed/27280291 http://dx.doi.org/10.1371/journal.pone.0156256 Text en © 2016 Ren et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ren, Wei
Zuo, Ran
Wang, Yao-Nan
Wang, Hong-Jie
Yang, Jian
Xin, Shao-Kun
Han, Ling-Yu
Zhao, Hai-Yu
Han, Shu-Yan
Gao, Bo
Hu, Hao
Hu, Yuan-Jia
Bian, Bao-Lin
Si, Nan
Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction
title Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction
title_full Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction
title_fullStr Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction
title_full_unstemmed Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction
title_short Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction
title_sort pharmacokinetic-pharmacodynamic analysis on inflammation rat model after oral administration of huang lian jie du decoction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900566/
https://www.ncbi.nlm.nih.gov/pubmed/27280291
http://dx.doi.org/10.1371/journal.pone.0156256
work_keys_str_mv AT renwei pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT zuoran pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT wangyaonan pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT wanghongjie pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT yangjian pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT xinshaokun pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT hanlingyu pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT zhaohaiyu pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT hanshuyan pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT gaobo pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT huhao pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT huyuanjia pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT bianbaolin pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction
AT sinan pharmacokineticpharmacodynamicanalysisoninflammationratmodelafteroraladministrationofhuanglianjiedudecoction